link to homepage

Institute of Neuroscience and Medicine

Navigation and service

Molecular Neuroimaging

The focus of our research is on metabolic and neurochemical processes which underlie fundamental functions of the brain (e. g. sleep-wake regulation) and neurological and psychiatric diseases (e.g. dementia, depression).

For this purpose, we employ different imaging and analytical techniques, among others positron emission tomography (PET), functional and pharmacological magnetic resonance imaging (MRI), electroencephalography (EEG), laboratory techniques (microdialysis, autoradiography, immunohistochemistry etc.), kinetic analysis etc. Further information about methods and protocols is available here.

With regard to basic neuroscience we use multimodal imaging techniques to investigate the role of adenosine and its antagonist caffeine on sleep regulation and cognition as well as long term effects of caffeine on brain ageing and neurodegeneration.

Our preclinical research concentrates on the evaluation of diagnostic and therapeutic drugs. Here you will find more information.

The main goal of our clinical research is developing highly specific neurochemical indicators for brain diseases, which allow a reliable diagnosis in an early state of disease (particularly in neurodegenerative disorders including Alzheimer’s and Parkinson’s). In this context, we are conducting clinical trials using molecular neuroimaging for the approval of candidate compounds for diagnosis and therapy (in collaboration with industrial partners). An overview of our clinical studies is provided here.

Team "Molecular Pasticity" more









Dear visitor,

To make our website suit your needs even more and to give it a more appealing design, we would like you to answer a few short questions.

Answering these questions will take approx. 10 min.

Start now Close window

Thank you for your support!


In case you have already taken part in our survey or in case you have no time to take part now, you can simply close the window by clicking "close".

If you have any questions on the survey, please do not hesitate to contact:


Your Team at Forschungszentrum Jülich


Note: Forschungszentrum Jülich works with the market research institute SKOPOS to anonymously conduct and analyze the survey. SKOPOS complies with the statutory requirements on data protection as well as with the regulations of ADM (Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V.) and ESOMAR (Europäische Gesellschaft für Meinungs- und Marketingforschung). Your data will not be forwarded to third parties.